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Ryanodine receptors (RyR) function as Ca2 channels that regulate Ca2 release from intracellular stores to control a
diverse array of cellular processes. The massive cytoplasmic domain of RyR is believed to be responsible for regulating
channel function. We investigated interaction between the transmembrane Ca2-releasing pore and a panel of cytoplas-
mic domains of the human cardiac RyR in living cells. Expression of eGFP-tagged RyR constructs encoding distinct
transmembrane topological models profoundly altered intracellular Ca2 handling and was refractory to modulation by
ryanodine, FKBP12.6 and caffeine. The impact of coexpressing dsRed-tagged cytoplasmic domains of RyR2 on intracel-
lular Ca2 phenotype was assessed using confocal microscopy coupled with parallel determination of in situ protein:
protein interaction using fluorescence resonance energy transfer (FRET). Dynamic interactions between RyR cytoplasmic
and transmembrane domains were mediated by amino acids 3722–4610 (Interacting or “I”-domain) which critically
modulated intracellular Ca2 handling and restored RyR sensitivity to caffeine activation. These results provide com-
pelling evidence that specific interaction between cytoplasmic and transmembrane domains is an important mechanism
in the intrinsic modulation of RyR Ca2 release channels.
INTRODUCTION
Ryanodine receptors are large tetrameric channels that co-
ordinate Ca2 release from the sarco/endoplasmic reticu-
lum to directly regulate Ca2-dependent cellular processes
(Berridge et al., 2000; Carafoli, 2002; Fill and Copello, 2002).
Modulation of RyR Ca2 release activity is achieved by the
concerted actions of numerous intracellular effectors includ-
ing localized [Ca2], phosphorylation and nitrosylation, cel-
lular redox status, and the intrinsic organization of RyR into
arrays (Meissner, 1994; Eu et al., 2000; Yin and Lai, 2000; Sun
et al., 2001; Williams et al., 2001). The transmembrane car-
boxyl-terminal (C-terminus)1000 aa of RyR constitutes the
Ca2-releasing pore (Bhat et al., 1997; Xu et al., 2000) and
contains the site of ryanodine binding (Callaway et al., 1994;
Witcher et al., 1994), multiple interactive Ca2 inactivation
sites (Du and MacLennan, 1999) and is critical for tetrameric
oligomerization of the intact RyR channel (Gao et al., 1997;
Stewart et al., 2003). Aberrant regulation of the RyR Ca2-
releasing pore is pathogenic and is implicated in heart fail-
ure, malignant hyperthermia (MH), and stress-induced ven-
tricular tachycardia (Marx et al., 2000; McCarthy et al., 2000;
George et al., 2003a). The amino (N)-terminus of RyR, which
contains numerous modular regulatory domains (Williams
et al., 2001), is proposed to interact with the Ca2 pore to
modulate Ca2 release through the intact RyR channel pore
in vitro (Ikemoto and Yamamoto, 2000), and defective intra-
RyR interactions are likely to be causative of aberrant Ca2
release in RyR-linked pathology (Zorzato et al., 1996; El-
Hayek et al., 1999; Yamamoto et al., 2000; Yamamoto and
Ikemoto, 2002). Activation of the RyR channel is associated
with conformational reorganization of the cytoplasmic N-
terminal catalytic structure and rotation of the C-terminal
transmembrane assembly (El-Hayek et al., 1995; Orlova et al.,
1996; Sharma et al., 2000).
The precise topology of the transmembrane (TM) region
within the RyR C-terminus also remains to be fully defined
with models predicting 4, 6, and 10 TM-spanning segments
(Takeshima et al., 1989; Zorzato et al., 1990; Tunwell et al.,
1996; Du et al., 2002). Although cryo-EM studies demon-
strated that the TM domain could physically accommodate
10 membrane-spanning domains (Orlova et al., 1996; Sharma
et al., 2000), complementary strategies predicted that the
C-terminus of each RyR subunit contains four or six TM-
spanning regions (Callaway et al., 1994; Witcher et al., 1994;
Grunwald and Meissner, 1995; Bhat et al., 1997; Du et al.,
2002). The four-TM model is further supported by the find-
ing that TM9 (Zorzato et al., 1990)/TM5 (Tunwell et al., 1996)
forms part of the ion conduction pore (P-loop) analogous to
that identified in Streptomyces lividans K channel (Doyle et
al., 1998) and is therefore not membrane spanning (Balshaw
et al., 1999). Consequently, to preserve the cytoplasmic ori-
entation of the RyR N- and extreme C-termini (100 aa),
TM3 (Tunwell et al., 1996)/TM7 (Zorzato et al., 1990) is
unlikely to be a bona fide membrane-spanning domain on
the basis of its relatively low hydrophobicity and lack of
homology with other Ca2-releasing channels (Williams et
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al., 2001; Du et al., 2002). This revised model of transmem-
brane assembly is supported by biophysical characterization
of the RyR conduction pore, which demonstrated a voltage
drop nearer the lumenal side of the membrane, consistent
with the existence of a P-loop structure (Tinker and Wil-
liams, 1995) and that mutagenesis of the putative RyR selec-
tivity filter (GGIGD motif) significantly altered single-chan-
nel conductance, ionic selectivity, caffeine sensitivity, and
ryanodine binding (Zhao et al., 1999; Gao et al., 2000; Du et
al., 2001; Chen et al., 2002).
We therefore postulated that residues 3900–4450
(TM1–4; Zorzato et al., 1990) in the human cardiac RyR do
not form TM domains, but rather that they represent regions
of hydrophobicity that facilitate the spatial organization of
the N- and C-terminal domains in the intact channel and
permit the transduction of complex cytoplasmic modulatory
events to the Ca2 channel pore. To investigate this hypoth-
esis, we inducibly expressed eGFP-tagged RyR2 fragments
corresponding to the putative 4TM and 10TM arrangements
(aa 4485–4967 and aa 3722–4967, respectively) in combina-
tion with dsRed-tagged RyR2 cytoplasmic (N-terminal) do-
mains to more precisely determine, 1) the modulatory inter-
actions that occurred between the N- and C- terminal
domains and 2) the effect of such interactions on Ca2 ho-
meostasis in a cellular context. IntraRyR interactions occur
below the limit of resolution of light microscopy, and we
used fluorescence resonance energy transfer (FRET; Day et
al., 2001; Kenworthy, 2001; Truong and Ikura, 2001) between
the eGFP and dsRed fusion partners to monitor the associ-
ation between these domains. Our results provide direct
evidence for functional coupling between disparate regions
of the RyR mediated by an interacting domain (“I”-domain;
3722–4610 amino acids) that plays a pivotal regulatory role
in Ca2 channel function.
MATERIALS AND METHODS
Construction of TM and Cytoplasmic RyR2 Domains
A cDNA fragment of human RyR2 (Tunwell et al., 1996) encoding the open
reading frames (ORF) of 13574–15023 bp (aa 4485–4967; RyR24TM) was gen-
erated by PCR amplification using Pfu polymerase and oligonucleotides (5
cccgccgccaccatggcatatcaacagaaactt 3/5 cagcatttagctggtcttcatactgtt 3). A Hin-
dIII/XhoI (11288–15335 bp) fragment of RyR2 encoding amino acids 3722–
4967 (RyR210TM) was excised. RyR2 cassettes were inserted in-frame at the
carboxyl-terminus of enhanced green fluorescent protein (eGFP) in peGFP-C3
(CLONTECH, Palo Alto, CA) and eGFP-tagged RyR24TM and RyR210TM were
subsequently transferred into pIND (Invitrogen, Carlsbad, CA) at NheI/
BamHI restriction sites. Although we have named the longer recombinant
fragment RyR210TM because it was originally proposed to encode 10 TM
domains (Zorzato et al., 1990) and refer to it as such throughout this study, it
should be noted that this construct may encode the four or six TM arrange-
ments (Takeshima et al., 1989; Tunwell et al., 1996; Du et al., 2002). Similarly,
RyR24TM may also encode six TM domains (Tunwell et al., 1996).
A SpeI/NheI fragment of RyR2 (12–10015 bp) encoding amino acids
1–3298 was inserted in frame at the 5 terminus of the red fluorescent protein
from Discosoma (dsRed; Matz et al., 1999) in pdsRed-N1 (CLONTECH) to
generate p3298Red. A NheI-HindIII fragment (10015–11288 bp; 3298–3722 aa)
was ligated into pdsRed followed by subsequent insertion of the SpeI/NheI
fragment (1–3298 aa) to create p3722Red. To generate p4353Red and p4610Red,
we constructed an intermediate (pIntRed) by amplifying 10015–12088 using
oligonucleotides (5 gaagaggctagcagtgttttcccagcctat 3/5 attaccctcgagcatgga-
cagcaacatgac 3 containing NheI and XhoI restriction sites, respectively). The
introduction of an XhoI site (ctcgag vs. ttagaa in wild-type human RyR2)
retained the amino acid code (Leu-Glu). The 2.07-kb fragment was digested
with NheI/XhoI and ligated into p3298Red to create pIntRed. cDNA fragments
corresponding to 12072–13193 and 12072–13948 bp were amplified from
full-length RyR2 using oligonucleotides containing XhoI linkers and were
ligated into pIntRed to create p4353Red or p4610Red, respectively. All plasmid
propagation was done in Escherichia coli XL-10Gold (Stratagene, La Jolla, CA)
as described previously (George et al., 2003c) and constructs were verified by
automated sequencing (ABI3100; Applied Biosystems, Foster City, CA).
Expression of RyR2 TM and Cytoplasmic Domains
Stable populations of CHO cells transfected with pVgRxR (Invitrogen;
CHORxR) were selected and maintained in complete Ham’s F-12 medium
(George et al., 2003c) containing zeocin (500 g/ml). Postselection, CHORxR
cells stably expressing RyR2 C-termini were further selected using G418
sulfate (500 g/ml). The expression levels and intracellular targeting of
RyR24TM and RyR210TM in clonally derived cell populations (60 clones)
were determined after induction with ponasterone A (ponA; 5 M, 24 h; No
et al., 1996). Cell clones exhibiting the highest induction of RyR24TM (clone G7)
or RyR210TM (clone E6) were isolated and used throughout this study.
CHORxR, G7, or E6 were transfected with 3298Red, 3722Red, 4353Red, or
4610Red using Lipofectamine 2000 (Invitrogen). After transfection with RyR2
N-terminal domains (36–48 h posttransfection), expression of RyR24TM or
RyR210TM in G7 or E6, respectively, was induced using ponA (5 M, 24 h).
Experiments were performed on cells 72 h after the transfection of dsRed-
tagged RyR2 N-termini, which appeared to maximize the green-to-red mat-
uration of the dsRed fluorophore (Baird et al., 2000).
The induction profile of recombinant protein expression in G7 and E6 cell
lines was determined after addition of ponA (0–20 M) for 24 h. Microsomal,
nuclear, and cytoplasmic fractions were prepared and immunoblotted as
described previously using anti-RyR2 antibodies pAb129 (epitope: RyR2 aa
4674–4697) or pAb2143 (epitope: RyR2 aa 91–105) followed by detection
using donkey anti-rabbit antibody conjugated to horseradish peroxidase
(Santa Cruz Biotechnology, Santa Cruz, CA) and chemiluminescence reagents
(Supersignal, Pierce, Rockford, IL; George et al., 2003c). To determine the
subcellular localization of recombinant protein in G7 or E6 cells, constructs
were induced with ponA (5 M) and were visualized using eGFP (Ex 488 nm,
Em 507 nm) or dsRed (Ex 558 nm, Em 583 nm) fluorescence using a confocal
microscope (RS2; Leica, Heidelberg, Germany). Confocal analysis of in situ
protein:protein association between eGFP-tagged RyR2 TM and coexpressed
dsRed-tagged cytoplasmic domains was performed as described previously
(George et al., 2003a, 2003c).
Immunoprecipitation of RyR2 Domains
After induction with ponA (5 M, 24 h), G7 and E6 cells expressing RyR2
N-terminal domains were homogenized in immunoprecipitation (IP) buffer
(150 mM NaCl, 20 mM Tris, 2 mM DTT, 0.3% [wt/vol] CHAPS; pH 7.4) for 2 h
at 4°C with constant orbital rotation. Samples were centrifuged (1500  g, 10
min), and the supernatants were incubated with pAb129 (C-terminal) or
pAb2143 (N-terminal; 1:200 dilution) for 36 h at 4°C. After incubation with
protein G-agarose (20 l; Santa Cruz Biotechnology; 1 h at 4°C) immunocom-
plexes were pelleted by centrifugation (2500  g, 2 min), washed with IP
buffer (3  1 ml) and immunoblotted using pAb129 or pAb2143 as described
above.
[3H]Ryanodine Binding of RyR2 TM Domains
Microsomal fractions from G7 and E6 cells (uninduced or after incubation
with ponA; 5 M, 24 h) were obtained using an osmotic lysis procedure
(George et al., 2003c), and their specific ryanodine binding capacity was
determined using a modification of a previous method (Holmberg and Wil-
liams, 1990). Briefly, membrane fractions were incubated with [3H]ryanodine
(10 nM, Amersham) for 90 min at 37°C in a basic binding buffer (25 mM
PIPES, 1 mM KCl; pH 7.4) containing 100 M free [Ca2]. Nonspecific
binding was measured by coincubation with excess unlabeled ryanodine (10
M). Bound [3H]ryanodine was separated from unbound using vacuum
filtering through glass fiber filters (Whatman GF/F, Clifton, NJ) and filter-
bound radioactivity was quantified by liquid scintillation counting. Micro-
somes obtained from cells expressing full-length RyR2 (George et al., 2003b,
2003c) were used as controls.
Measurement of Intracellular [Ca2] and pH
In situ calibration of calcium crimson was performed in streptolysin O–per-
meabilized cells using buffers containing 0–39 M free [Ca2] (George et al.,
2003b). Cells were loaded with calcium crimson (5 M in Krebs-Ringer-
HEPES (KRH) containing 1.3 mM CaCl2 (KRHCa2; George et al., 2003c) for
2 h at 30°C and transferred to KRH containing nominal free Ca2 (KRH-Ca2,
which contained 1 mM EGTA in place of 1.3 mM CaCl2) immediately before
experiments. Caffeine (10 mM) or 4-chloro-m-cresol (4-CMC, 1 mM) were
used to trigger RyR-dependent intracellular Ca2 release. In some experi-
ments, cells were preincubated with ryanodine (1 mM) for 90 min and
throughout the experiments and in others, cells were transfected with plas-
mid encoding human FKBP12.6 (George et al., 2003c). To clamp intracellular
[Ca2] in G7 and E6 cells, cells were incubated in solutions containing known
free [Ca2] (approximately 150 nM and 300 nM, respectively) in the presence
of ionomycin (1 M, 30 min). Data were acquired from eGFP/dsRed-positive
cells every 100 ms using a confocal microscope (RS2, Leica) and numerical
data obtained from defined intracellular regions was converted to [Ca2]
(George et al., 2003b).
The intracellular pH of G7 or E6 cells expressing RyR2 N-termini was
determined after the loading of BCECF-AM (2 M, 45 min) and in situ
calibration of H-dependent BCECF fluorescence in KRH solutions at known
C.H. George et al.
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pH (pH 5.0–9.1) in the presence of nigericin (50 M) and KCl (100 mM) using
dual-wavelength excitation spectrophotometry (440 nm/490 nm; LS50B, Per-
kin Elmer-Cetus, Boston, MA). A pKa of 7.132 (Hill slope 0.559) was derived
from nonlinear regression of the data using Prism software (GraphPad, San
Diego, CA) and was used to obtain pH values from fluorescent data as
described (Haugland, 1996).
Measurement of Fluorescence Resonance Energy Transfer
Fluorescence resonance energy transfer (FRET) between eGFP-tagged RyR2
TM domains and dsRed-tagged cytoplasmic domains was measured using
the parameters described previously (Mizuno et al., 2001). Briefly, induced G7
and E6 cells coexpressing cytoplasmic RyR2 domains were excited at 488 nm
(Exmax eGFP) and fluorescent emission were monitored at 507 nm (Emmax
eGFP) and 583 nm (Emmax dsRed). An increased Em 583:Em 507 ratio is a
robust indicator of FRET occurring between eGFP and dsRed (Mizuno et al.,
2001). The FRET ratio (Em 583/507) was measured in single cells using a
confocal microscope (Leica RS2) configured to 4 oversampling (voxel
size  40 nm3) in identical experiments to those in which intracellular [Ca2]
was determined. Numerical data was obtained from regions of interest fo-
cused to the immediate vicinity of membrane-associated eGFP-tagged RyR2
TM domains to minimize the contribution of cytoplasmic dsRed-tagged con-
structs occurring in the bulk cytoplasm to the FRET signal. Data were ob-
tained from at least 60 cells using Leica software.
RESULTS
Characterization of the RyR2 TM Domain Using an
Inducible Cell Model
cDNA constructs encoding the RyR2 TM and cytoplasmic
domains used in this study are illustrated schematically in
Figure 1. Cell lines G7 (RyR24TM) and E6 (RyR210TM) did not
express detectable levels of recombinant RyR2 TM domains
in the absence of ponA (Figure 2A). However, RyR2 TM
domains of the predicted sizes (MW 85.6 and 170.9 kDa for
eGFP-tagged RyR24TM and RyR210TM, respectively) were
expressed in a dose-dependent manner after exposure of the
cells to ponA (2–20 M; Figure 2A). In situ detection of
recombinant RyR2 TM domains in G7 and E6 cells using
eGFP fluorescence confirmed a dose-dependent induction
profile of RyR24TM and RyR210TM, respectively (Figure 2B).
Increased expression levels of TM domains (10 M ponA)
were associated with altered morphology (which was par-
ticularly pronounced in G7 cells), indicative of cellular tox-
icity (Figure 2B). Consequently, in subsequent experiments,
ponA (5 M) was used to induce sufficient TM domain
expression to perform the experiments but which avoided
the toxic effects associated with higher levels of RyR2 TM
domain expression. RyR24TM and RyR210TM were detected
Figure 1. Schematic repre-
sentation of truncated hRyR2
constructs. Putative TM re-
gions (white bars) in RyR24TM
and RyR210TM were reported
previously (Takeshima et al.,
1989; Zorzato et al., 1990).
These constructs may also en-
code six TM-spanning regions
(Du et al., 2002; see MATERI-
ALS AND METHODS). Do-
mains A, B, and C represent
putative functional regions
within RyR2 predicted from
primary sequence analysis
and from data obtained else-
where (Chen et al., 1998; Du
and MacLennan, 1999; Porter
Moore et al., 1999; Du et al.,
2000; Sun et al., 2001). Dotted
and striped bars represent
eGFP and dsRed, respectively.
Figure 2. Heterologous expression of RyR2 TM domains in G7 and
E6 cells. (A) Microsomal fractions (100 g) obtained from G7 and E6
cells after ponA induction (0–20 M) of RyR24TM and RyR210TM,
respectively, were immunoblotted using pAb129. (B) Endogenous
eGFP fluorescence was used to visualize RyR24TM and RyR210TM in
G7 and E6 cells, respectively, after induction with ponA (0–20 M).
Bar, 10 m. (C) Nuclear (N), microsomal (M), and cytosolic (C)
fractions (100 g) obtained from CHORxR, G7, and E6 cells exposed
to ponA (5 M) were immunoblotted using pAb129. (D) Intracellu-
lar localization of RyR2 TM domains in G7 and E6 cells after
induction with ponA (5 M). Bar, 5 m.
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only in microsomal fractions obtained from G7 and E6 cells,
respectively (Figure 2C, lanes M) and not in nuclear or
cytosolic fractions (lanes N and C, respectively). CHORxR
did not express detectable levels of RyR in any subcellular
fraction (Figure 2C). RyR24TM and RyR210TM in G7 and E6,
respectively, exhibited endoplasmic reticulum (ER) localiza-
tion characterized by a lattice-like distribution (Figure 2D).
After calibration of the Ca2-dependent fluorescence of
calcium crimson in living cells (Kd(app)  493 nM, Hill
Slope 1.35), similar resting [Ca2]c in G7 (103 9 nM) and
E6 (92  11 nM) cells were determined in the absence of
ponA (Figure 3A, gray traces). After induction with a dose of
ponA (5 M), which induced expression of RyR2 TM do-
mains but otherwise had little nonspecific effect on cell phe-
notype (Figure 2B), resting [Ca2]c was markedly elevated
in G7 (279  41 nM) and E6 (154  23 nM) cells (Figure 3A,
black traces) strongly indicating that RyR2 TM domains
form Ca2-permeable conduits, entirely consistent with
other studies (Bhat et al., 1997; Xu et al., 2000). Notably,
similar expression levels of the RyR2 TM domains are
achieved in G7 and E6 cells using this induction protocol (5
M ponA, 24 h; Figure 2, A and B) and thus the different
resting [Ca2]c measured in induced G7 and E6 cells was
unlikely to be underscored by the differential expression of
these Ca2 permeable structures. Resting [Ca2]c in induced
G7 or E6 cells was not altered after incubation with ryano-
dine, a specific modulator of intact RyR, or after coexpres-
sion of FKBP12.6, a potent modulator of full-length RyR2
Ca2 release channels (George et al., 2003b, 20023c; G7:
261  37 and 308  31 nM, respectively; E6: 162  44 nM,
171  29 nM, respectively; Figure 3B). Consistent with these
results suggesting that the Ca2-releasing channels formed
from RyR24TM and RyR210TM were refractory to modifica-
tion by ryanodine in a cellular context, microsomal fractions
obtained from induced G7 and E6 cells exhibited insignifi-
cant binding of [3H]ryanodine (7.3  5.9 and 5.2  1.2
fmol/mg protein, respectively) when compared with micro-
somes containing comparable levels of full-length recombi-
nant RyR2 (George et al., 2003c; 82.6 1.7 fmol/mg protein).
Further, neither uninduced nor induced G7 and E6 cells
(gray and black traces, respectively) were responsive to ad-
dition of caffeine (10 mM, arrowed), a potent RyR agonist,
indicating that the Ca2-permeable structures formed by
RyR24TM and RyR210TM were insensitive to caffeine activa-
tion (Figure 3C). Intracellular [Ca2] remained unchanged
after addition of 4-CMC (1 mM) to induced G7 cells, but
importantly, the addition of 4-CMC (1 mM) triggered a
moderate but persistent increase in [Ca2]c in induced E6
cells only (186  20 nM; Figure 3C, black traces). Uninduced
G7 and E6 cell lines did not respond to 4-CMC (Figure 3D,
gray traces), directly indicating that the [Ca2] increase in E6
cells after 4-CMC addition was indeed mediated by
RyR210TM. This finding highlights that amino acid residues
within RyR210TM confer sensitivity to activation by 4-CMC
and is entirely consistent with the recent positional mapping
of critical determinants of 4-CMC activation of RyR1 (Fes-
senden et al., 2003). However, it should be noted that the
magnitude of 4-CMC activation of Ca2 release in E6 cells
was markedly lower (7%) than was measured in cells
expressing full-length RyR2 after 4-CMC addition (753  41
nM, where the percentage change in [Ca2] relative to rest-
ing [Ca2] was assigned 100%; Figure 3D). Also, caffeine (10
mM) elicited a large mobilization of Ca2 through full-
length recombinant RyR2, demonstrating that the agonist-
response of full-length RyR2 in these cells remained intact
(Figure 3D).
Identification of an RyR2 Domain that Mediates N- and
C-terminal Interaction
To determine the functional role of interdomain interaction
on RyR Ca2 release, we investigated the effects of coex-
pressing a panel of dsRed-tagged RyR2 amino-terminal do-
mains on intracellular Ca2 handling in G7 and E6 cells (see
Figure 3. Intracellular Ca2 handling in G7 and E6 cells. (A) Rest-
ing [Ca2]c was measured in uninduced G7 and E6 cells maintained
in nominal free [Ca2] (gray traces) or after induction (ponA, 5 M)
of expression of RyR24TM and RyR210TM, respectively (black traces).
(B) Resting [Ca2]c was measured in G7 and E6 cells or those
pretreated with ryanodine or coexpressing FKBP12.6. The absence
() or presence () of reagents is given. Data are plotted as
means SEM (n 5 with30 cells analyzed in each instance). *p	
0.01. (C) The effect of caffeine (10 mM) or 4-CMC (1 mM) on
intracellular Ca2 release in uninduced (gray traces) or induced
(black traces) G7 and E6 cells. Arrow indicates addition of agonist.
(D) The effect of caffeine (10 mM) (C) or 4-CMC (1 mM) (D) on
intracellular Ca2 release in G7 and E6 cells expressing full-length
RyR2. Arrow indicates agonist addition. Bar, 10 s.
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Figure 1). Immunoblot analysis confirmed that recombinant
proteins of the predicted molecular mass; 3298Red (397.7
kDa) 	 3722Red (447.3 kDa) 	 4353Red (518.2 kDa) 	 4610Red
(548.7 kDa) were expressed only in the cytoplasm of CHORxR
(Figure 4A, left panel) and not in microsomal fractions (Figure
4A, right panel). In contrast, recombinant full-length RyR2 was
abundant in microsomal preparations but totally absent in
cytoplasmic fractions (Figure 4A, right and left panels, respec-
tively), consistent with the identification of a membrane reten-
tion sequences in the extreme RyR carboxyl-terminus (Bhat
and Ma, 2002). Expression of RyR2 N-terminal domains did
not alter resting [Ca2] in CHORxR cells and did not confer
agonist-sensitive Ca2 release after addition of caffeine or
4-CMC to cells (Figure 4B), strongly indicating that 3298Red,
3722Red, 4353Red, and 4610Red do not form Ca2-permeable
structures in our cell system. Furthermore, these data suggest
that RyR2 N-termini do not interact with other Ca2-releasing
moieties in CHORxR cells because these cells remain refractory
to RyR agonist-sensitive Ca2 release after their expression. In
agreement with our subcellular fractionation data (Figure 2C),
recombinant RyR2 N-terminal domains were characterized by
homogeneous distribution throughout the cytoplasm in
CHORxR cells (Figure 4C). Both 3298Red and 3722Red were
abundantly expressed in the cytoplasm in induced G7 and E6
cells (Figure 4C, red), indicating minimal in situ association
with either RyR24TM or RyR210TM. In contrast, there was a
striking subcellular redistribution of 4353Red toward intracel-
lular membranes in induced E6 cells, but not in G7 cells (Figure
Figure 4. Characterization of re-
combinant RyR2 amino-terminal
domains. (A) Cytoplasmic (left
panel) and microsomal (right
panel) fractions (100 g) obtained
from CHORxR cells expressing
RyR2 N-terminal constructs were
immunoblotted using pAb2143.
Full-length recombinant RyR2
was used as control (MW 565
kDa). (B) Intracellular Ca2 in
CHORxR cells expressing RyR2 N-
terminal domains was deter-
mined in resting cells and after
the addition of caffeine (10 mM,
top traces) and 4-CMC (1 mM, bot-
tom traces; arrowed). Bar, 10 s. (C)
The localization of RyR2 domains
in CHORxR or G7 and E6 cells in-
duced with ponA (5 M) was de-
termined using confocal micros-
copy. Coincidence of eGFP-tagged
RyR2 TM domains (green) and
dsRed tagged N-terminal domain
(red) appears yellow. Bar, 10 m.
(D) Analysis of coincident staining
between eGFP- and dsRed-tagged
RyR2 constructs is expressed as the
percentage of total cellular fluores-
cent signal of the RyR TM domains
(green) that could be directly over-
laid with fluorescence signal from
dsRed tagged fusion proteins at
1024  1024 pixel resolution. G7
and E6 cells are represented as
white and black bars, respectively.
*p 	 0.005 when compared with
cells expressing untagged dsRed
(n  4, 12 cells per experiment).
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4C). The majority of RyR24TM and RyR210TM in G7 and E6 cells,
respectively, were colocalized with 4610Red that exhibited ex-
tensive intracellular membrane localization (Figure 4C). Nu-
merical analysis of pixel coincidence as a robust indicator of in
situ protein:protein association (George et al., 2003a, 2003c)
demonstrated that sequence overlap between cytoplasmic and
TM domains (broadly mapped to amino acids 3722–4610) pro-
moted a marked sequestration of 4353Red and 4610Red to ER
membranes containing RyR2 TM domains and provided good
evidence of in situ association between RyR2 TM and cytoplas-
mic regions (Figure 4D). It should be noted that our analysis of
RyR2 domain coincidence at high pixel resolution (1024 
1024) specifically focused on the extent of association between
ER membrane-localized TM domains with RyR2 N-terminal
regions and thus represents a relative index of RyR2 N-termi-
nal sequestration to ER membranes.
Using mild coimmunoprecipitation conditions (see MATE-
RIALS AND METHODS) high-titer antipeptide antibodies
raised against RyR2 carboxyl (pAb129) and amino-terminal
(pAb2143) epitopes did not immunoprecipitate RyR2 cytoplas-
mic and TM domains, respectively, from postnuclear superna-
tants from transfected G7 and E6 cells, although these antibod-
ies did immunoprecipitate the corresponding RyR2 domain
(Figure 5A). Our coimmunoprecipitation methodology was
validated by the coimmunoprecipitation of recombinant
FKBP12.6 from cells which coexpressed full-length RyR2
(George et al., 2003c; Figure 5B, lane 1), an interaction that could
be disrupted by incubation of the cells with rapamycin (Figure
5B, lane 2). These results suggested that the association be-
tween RyR2 TM and cytoplasmic domains was mediated by
weak protein:protein interactions.
RyR2 N- and C-terminal Interaction Critically Modulate
Intracellular Ca2 Handling
We next determined if the specific association between RyR2
TM and cytoplasmic domains, which was mediated by
amino acids 3722–4610, had a functional impact on the
intracellular Ca2 phenotype. We coupled determination of
intracellular Ca2 handling with FRET measurements be-
tween the eGFP and dsRed fusion partners (Mizuno et al.,
2001; Erickson et al., 2003) to monitor in situ protein:protein
association below the resolution limit of light microscopy
(Day et al., 2001; Kenworthy, 2001; Truong and Ikura, 2001).
After expression of dsRed, resting [Ca2] remained unal-
tered and the lack of caffeine and 4-CMC sensitivity per-
sisted when compared with non-dsRed–expressing induced
G7 and E6 cells (Figure 6A, black traces, vs. Figure 3C). This
data when taken together with the relatively low FRET
signal determined in these cells ( 0.6; Figure 6A, gray
traces) indicated negligible interaction between dsRed and
RyR24TM or RyR210TM. Coexpression of 3298Red and 3722Red
in G7 and E6 cells did not affect resting [Ca2]c, caffeine, or
4-CMC activation profiles (Figures 6, B and C, black traces,
and 7), and FRET measurements were similar to those ob-
tained in control cells expressing dsRed (Figures 6, B and C,
gray traces, and 7), strongly suggesting that that 3298Red and
3722Red did not physically or functionally interact with
RyR24TM or RyR210TM.
In marked contrast, 4353Red demonstrated a dual mode of
intracellular Ca2 regulation in induced E6 cells, where its
expression 1) significantly decreased resting [Ca2]c (Fig-
ures 6D, black trace, and 7A) and 2) restored caffeine-sensi-
tive Ca2 release to E6 cells expressing RyR210TM (Figures
6D, black trace, and 7B). These phenomena were associated
with a significant increase in resting FRET ratio (0.72) and
caffeine-induced changes in the FRET signal (Figures 6D,
gray trace, and 7, D and E), indicative of both increased
steady-state interaction between 4353Red and RyR210TM (Fig-
ure 7D) and caffeine-induced alterations in N- and C-termi-
nal interaction (Figure 7E). This finding is in full agreement
with our confocal analysis demonstrating in situ association
between 4353Red and RyR210TM (Figure 4, C and D), but
Figure 5. Interdomain association is mediated by weak protein:protein interaction. (A) Coimmunoprecipitation analysis of ponA induced
(5 M) G7 and E6 cells coexpressing 3298Red, 3722Red, 4353Red, and 4610Red. Postnuclear supernatants were immunoprecipitated using either
pAb2143 (anti-N terminus) or pAb129 (anti-C terminus) and followed by immunoblotting using pAb2143 or pAb129 as described in
MATERIALS AND METHODS. (B) Cell lysates (300 g) from cells coexpressing recombinant FKBP12.6 and full-length RyR2 (George et al.,
2003c) were processed for immunoprecipitation using pAb129, and after separation using SDS-PAGE (20% acrylamide; vol/vol), FKBP12.6
was detected in the absence and presence of rapamycin (5 M; lanes 1 and 2, respectively) using pAbN-19 (Santa Cruz Biotechnology).
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significantly extends it further by revealing the functional
impact of interdomain interaction on intracellular Ca2 han-
dling. Consistent with our data indicating that 4353Red did
not associate with RyR24TM (Figure 4, C and D), expression
of 4353Red in G7 cells had little effect on resting [Ca2]c
(Figures 6D, black trace, and 7A), agonist-induced Ca2
release (Figure 6D, black traces and 7, B and C) and FRET
ratio (Figures 6D, gray trace, and 7, D–F).
Importantly, upon extension of the RyR2 N-terminal do-
main to 4610 amino acids (i.e., incorporation of domain C,
Figure 1), resting [Ca2]c was significantly decreased in both
G7 and E6 cells coexpressing 4610Red (Figures 6E, black
trace, and 7A) and was accompanied by an increased steady
state resting FRET signal in these cells (0.75; Figures 6E,
gray trace, and 7D). Expression of 4610Red further aug-
mented caffeine-induced Ca2 release in E6 cells when com-
pared with expression of 4353Red, and importantly 4610Red
also restored partial caffeine sensitivity in G7 cells (Figures
6E, black traces, and 7B). The 4610Red-mediated restoration
of caffeine sensitivity in both G7 and E6 cells was associated
with increased peak FRET signal after caffeine addition (Fig-
ures 6E and 7E). Furthermore, the sustained elevation in
[Ca2]c after the caffeine addition to E6 cells expressing
4610Red was associated with a profound increase in ampli-
Figure 6. Investigating the functional impact of RyR2 TM and cytoplasmic domain interaction. (A–E) [Ca2]c in single G7 and E6 cells (black
traces) coexpressing dsRed (A), 3298Red (B), 3722Red (C), 4353Red (D), or 4610Red (E) was measured before and after addition of caffeine or
4-CMC (arrowed). In parallel experiments, FRET (ratio 583:507; gray traces) between eGFP and dsRed fusion partners was determined. FRET
ratio traces in B (i) and E (ii) are expanded in F. (F) Emission spectra (black traces) of eGFP (507 nm) and dsRed (583 nm) before and after
addition of agonist (arrowed) used to derive the FRET ratio (gray traces) in B (i) and E (ii) are shown. Note that the caffeine-induced increase
in FRET ratio in E6 cells expressing 4610Red (F (ii)) is associated with decreased eGFP fluorescence and concomitantly increased dsRed
fluorescence. Traces shown are representative of 30 imaged “positive” (eGFP and dsRed fluorescent) cells. Bar, 10 s.
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tude variability in the FRET signal (Figure 6, E and F(ii)).
This data raises the intriguing possibility that the increased
“noise” in the FRET signal immediately after caffeine addi-
tion, which we logically interpret as agonist-induced confor-
mational instability between RyR2 cytoplasmic and TM do-
mains, may directly contribute to the sustained Ca2
increase after caffeine activation of RyR2. The 4-CMC acti-
vation profile in G7 and E6 remained unchanged after the
expression of all RyR2 cytoplasmic domains, suggesting that
CMC activation of RyR2 is independent of interaction be-
tween cytoplasmic and TM domains (Figure 7C).
It was important to validate the FRET signals determined
in these experiments, because FRET measurements may be
critically influenced by the cellular environment including
localized [Ca2] and intracellular pH gradients. However,
we have data strongly indicating that different intracellular
Ca2 environments in G7 and E6 cells did not contribute to
the FRET measured between the eGFP and dsRed fusion
partners in our experiments. First, the fluorescence emission
spectra obtained from eGFP and dsRed are particularly di-
agnostic of bona fide FRET occurring because in cells where
interaction occurs between RyR2 N-terminal and TM do-
mains, there is decreased steady state eGFP emission accom-
panied by a corresponding increase in dsRed emission in
resting cells, which is substantially augmented after caffeine
addition (Figure 6F, trace (ii) compared with trace (i)). Sec-
ond, using Ca2 permeabilization techniques (see MATERI-
ALS AND METHODS), the intracellular [Ca2] in G7 and E6
cells were clamped at 300 nM and 150 nM, thereby
reversing the resting intracellular Ca2 environments nor-
mally found in these cells after induction of RyR2 TM do-
mains (Figure 3C). Figure 8A shows that resting and caf-
feine-activated FRET signals after the switch in intracellular
[Ca2] in G7 and E6 cells expressing RyR2 N-terminal do-
mains were similar to those data obtained in intact G7 and
E6 cells (Figures 6 and 7). Thus, although the intracellular
[Ca2] in G7 and E6 cells was changed, the interactions of
4353Red and 4610Red with RyR24TM and RyR210TM in cells in
which the [Ca2] environment had been reversed (Figure
8A) were indistinguishable from the interactions determined
in previous experiments (Figures 6 and 7). This finding
strongly suggests that the different intracellular Ca2 envi-
ronments existing in induced G7 and E6 cells did not con-
tribute to the FRET signals determined in this study. Third,
intracellular pH in G7 and E6 cells expressing 3298Red,
3722Red, 4353Red, or 4610Red were similar in resting and
caffeine-stimulated cells (Figure 8B), further reinforcing that
although pH changes can affect FRET signals, differences in
intracellular pH were unlikely to contribute to the differ-
ences in FRET signals determined in G7 and E6 cells. Thus,
we interpret the increased resting FRET signals in E6 cells
expressing 4353Red and 4610Red or G7 cells expressing
4610Red (Figure 7D) as being due to increased proximity
between the eGFP and dsRed FRET partners due to associ-
ation between the N-terminal and TM domains of RyR2 and
that the significantly increased FRET ratio after caffeine ad-
Figure 7. Interaction between RyR2 cytoplasmic and TM domains modulate intracellular Ca2 in G7 and E6 cells. (A) Resting [Ca2]c
measured in induced G7 and E6 cells transfected with dsRed, 3298Red, 3722Red, 4353Red, and 4610Red. (B and C) Increases in [Ca2]c after
addition of caffeine (B) or 4-CMC (C) are represented as the percentage peak change in [Ca2]c (
Ca) when compared with resting [Ca2]c
(Cao). (D) Basal FRET signals (ratio 583:507) obtained from induced G7 and E6 cells expressing hRyR2 cytoplasmic domains. (E and F)
Maximum agonist-induced changes in FRET signals after addition of caffeine (E) or 4-CMC (F) are expressed as the peak change in the FRET
ratio (
ratio) when compared with the resting FRET ratio (ratioo). All experimental values are plotted as means  SEM (n  30 cells) where
the asterisk represents p 	0.01 when compared with G7 or E6 cells expressing untagged dsRed.
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dition is due to further rearrangement within the cytoplas-
mic and TM domain of RyR2 upon channel activation (Fig-
ures 6F and 7, E and F).
DISCUSSION
A novel in situ protein complementation approach was used
to demonstrate that interaction between heterologously ex-
pressed RyR2 cytoplasmic and TM domains critically mod-
ulates intracellular Ca2 handling and results in reconstitu-
tion of functional RyR2 channels. This finding provides the
first cell-based insight into the precise mechanisms by which
Ca2 release channels autoregulate their activity via inter-
domain interaction. RyR24TM and RyR210TM were correctly
targeted to the ER and formed Ca2-permeable conduits
that exhibited different functional characteristics. RyR24TM
and RyR210TM constructs were named according to the TM-
spanning regions they were originally predicted to form
(Takeshima et al., 1989; Zorzato et al., 1990), but more re-
cently a 6TM model has been predicted (Du et al., 2002).
Because it is highly unlikely that these constructs comprise
different TM arrangements, we interpret our results to sug-
gest that RyR24TM and RyR210TM form essentially the same
Ca2-permeable structure but that RyR210TM encodes addi-
tional modulatory regions (3722–4485 amino acids) that
serve to regulate RyR2 Ca2 release. This hypothesis is
supported by the findings that the expression of RyR24TM
caused a dramatic elevation in cytoplasmic [Ca2] in G7
cells, whereas cytoplasmic [Ca2] was markedly lower in E6
cells expressing RyR210TM despite equivalent levels of re-
combinant protein expression and that only RyR210TM was
sensitive to activation by 4-CMC. When taken together with
theoretical and experimental modeling of the RyR C-termi-
nus (Williams et al., 2001; Du et al., 2002), our results strongly
suggest that the 3722–4485 amino acid region of RyR2 con-
tains modulatory domains that are involved in Ca2 channel
regulation. This is entirely consistent with our hypothesis
that residues 3900–4500 do not form TM domains but that
they represent regions of hydrophobicity (numerical index:
0.133; Hopp and Woods, 1981) critically involved in Ca2
channel regulation. Furthermore, because the sequences en-
coding the 10TM model (Zorzato et al., 1990) are not present
in RyR24TM, our results also provide good evidence that the
C-terminus of RyR2 comprises an arrangement of four or six
TM domains. RyR24TM and RyR210TM were refractory to
modulation by ryanodine and FKBP12.6, emphasizing that
the three-dimensional conformation of these binding sites
requires the interaction of multiple domains in the intact
RyR (Bultynck et al., 2001; Fessenden et al., 2001). In contrast
to our findings, truncated RyR1 was modified by ryanodine
(Bhat et al., 1997), but these constructs contained significant
amino-terminal residues and thus the sole contribution of
the Ca2 pore-forming domain to ryanodine binding was
not determined. Although the Ca2-forming pore of RyR2
was not modulated by coexpressed FKBP12.6, a potent reg-
ulator of full-length RyR2 (George et al., 2003c), we cannot
exclude the possibility that the RyR2 TM domain bound
FKBP12.6 but that there was insufficient RyR2 modulatory
sequence present within these C-terminal domains to medi-
ate FKBP12.6-dependent Ca2 channel regulation.
Strikingly, we demonstrated a specific association be-
tween RyR2 cytoplasmic domains and the membrane local-
ized TM region, which resulted in inhibitory (suppressed
resting intracellular [Ca2]) and excitatory (restored caffeine
sensitivity) modulation of RyR Ca2 channel functionality.
The marked functional interaction of RyR2 cytoplasmic and
TM domains was mediated by weak physical interaction,
which may reflect the dynamic mode of RyR regulation
occurring in situ. By successive amino-terminal extension,
the region mediating interaction between RyR2 TM and
Figure 8. Investigating the impact of
intracellular Ca2 and pH environ-
ments on FRET between RyR2 cyto-
plasmic and TM domains. (A) The
resting FRET ratio (ratio 583/507;
white bars) or caffeine-induced
changes in the FRET ratio (
ratio/ra-
tioo; see Figure 7E legend; black bars)
were determined in G7 and E6 cells,
where intracellular [Ca2] was clamped
at approximately 150 and 300 nM, re-
spectively, as described in MATERIALS
AND METHODS. *p 	 0.01 when the
resting FRET signal is compared with
G7 or E6 cells expressing dsRed, and
**p 	 0.01 when 
ratio/ratioo is com-
pared with that measured in G7 or E6
cells expressing dsRed. n  3 with 15
cells analyzed in each experiment. The
data obtained from G7 and E6 cells ex-
pressing 3298Red or 3722Red did not at-
tain significance (i.e., p  0.05) in these
experiments. (B) Intracellular pH in
resting (white bars) and caffeine acti-
vated (10 mM; black bars) G7 and E6
cells expressing RyR2 N-terminal con-
structs was measured using BCECF (2
M) after in situ calibration of the dye
(see MATERIALS AND METHODS).
n  4 with 12 cells analyzed in each
experiment.
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cytoplasmic domains was mapped to amino-acid residues
3722–4610, which we termed the “interacting” or I-domain.
Because the determinants of intersubunit interaction in-
volved in RyR tetramerization are located in regions distinct
from the I-domain (Stewart et al., 2003), the I-domain prob-
ably mediates interaction within, and not between, RyR2
subunits in the intact tetramer. Because one RyR subunit
contains a single I-domain, the interaction demonstrated in
this study should be mediated by self-interaction within the
I-domain of each RyR subunit. In support of this hypothesis,
despite similar interaction with RyR210TM in resting cells
(Figure 7D), 4610Red significantly augmented caffeine-stim-
ulated Ca2 release when compared with these cells ex-
pressing 4353Red (Figure 7E). Thus, although amino acid
residues 3722–4353 (Domain B, Figure 1) appear sufficient
for interdomain interaction to occur with the RyR210TM re-
gion, residues 4353–4610 (Domain C, Figure 1) markedly
enhance the functional impact of this interaction. Therefore,
our results indicate that interaction occurs between discrete
regions of single I-domains, thereby resulting in the modu-
lation of interaction between the cytoplasmic and TM assem-
blies of RyR2 (Figure 9), pointing to an additional complex-
ity of interaction within the intact RyR that necessitates
further experimentation. Although we provide strong evi-
dence that the I-domain is essential for intraRyR interaction,
we also cannot exclude the possibility that other cellular
factors influence the association of RyR2 TM and N-terminal
domains and to this end, additional cellular factors affecting
RyR interdomain interaction are currently being investi-
gated. In a pathological context, the I-domain is the locus for
several mutations associated with ventricular tachycardia
(VT), where hyper-activation of the mutant RyR2 channel
occurs after exposure to emotional or physical stress (Priori
et al., 2002) and it will be interesting to determine whether
defective interaction of the I-domain within the intact RyR2
underlies the stress-induced VT phenotype. Clearly, a more
precise analysis of the functional motifs involved in the
intramolecular interaction which modulates RyR Ca2 re-
lease remains to be determined.
The ability to investigate the dynamics of intracellular
protein interaction below the limit of resolution of light
microscopy is a major utility of FRET and the present study
demonstrates the suitability of dsRed in partnering GFP in
FRET studies. The use of dsRed as fusion partner has been
restricted because of the slow maturation of the red fluoro-
phore and its obligatory tetramerization (Baird et al., 2000)
but we did not encounter many of the reported difficulties of
using dsRed, probably for the following reasons. First, our
experimental protocol allowed sufficient time (72 h) to
maximize the maturation of the red fluorophore, resulting in
negligible excitation of dsRed at the absorption maximum of
GFP (488 nm). Second, the RyR fusion partners are suffi-
ciently massive (400 kDa) to negate the destabilizing effect
of dsRed tetramerization on the correct folding of RyR2
domain structure. Third, the cytoplasmic domains of RyR
are ordered in a loosely packed tetrameric arrangement
within the native intact protein. Regarding these latter two
points, although we currently do not know whether the
dsRed-tagged RyR2 cytoplasmic domains adopt the com-
plex structure determined in the intact RyR (Sharma et al.,
2000), our results clearly show that the folded state of these
domains is both sufficient and necessary to modulate Ca2
release via the pore-forming domain in our experimental
system. However, it is acknowledged that potential prob-
lems may exist in using “tetrameric” dsRed as a fusion
partner in other systems and to this end, the development of
fluorescent dsRed monomers represents a significant ad-
vance in its use as a fusion partner (Campbell et al., 2002).
An important finding of the present work is that caffeine
activation of the channel required the transduction of mod-
ulatory events between the interacting cytoplasmic and TM
domains of RyR and was associated with rearrangement
within the protein:protein complex (Figure 9). This finding is
entirely consistent with the long-range conformational
changes associated with channel activation (Orlova et al.,
1996). Also, our results are in agreement with the demon-
stration that interaction occurs within the intact RyR tet-
ramer (Zorzato et al., 1996; Yamamoto et al., 2000; Yamamoto
and Ikemoto, 2002) but extend them further by showing that
intraRyR interaction has a profound impact on RyR channel
function and intracellular Ca2 handling in a live-cell con-
text, emphasizing the dynamic nature of intramolecular RyR
interactions that may occur in vivo. Our findings may also
represent a common regulatory mechanism of other Ca2
release channels, notably the inositol 1,4,5-trisphosphate re-
ceptor (IP3R), which also exhibits complex cytoplasmic ar-
chitecture (Jiang et al., 2002) and is also modulated by in-
tramolecular interaction (Uchida et al., 2003).
In summary, we propose a model of dynamic regulation
of the Ca2-releasing pore of RyR2 by cytoplasmic domains
in which intraRyR interaction is promoted by the specific
association of hydrophobic domains. In a pathological con-
text, defective regulation of RyR underlies aberrant Ca2
release (George et al., 2003a) and our cell-based model pro-
Figure 9. Schematic model of RyR regulation via interdomain
interaction. A basal interaction between the cytoplasmic N-terminus
of RyR2 and transmembrane C-terminus is mediated by amino
acids 3722–4610 (I-domain) and suppresses aberrant Ca2 release
via the Ca2-channel pore. Caffeine activation triggers a conforma-
tional reorganization within the I-domain of the RyR polypeptide
which results in increased FRET signal between dsRed and eGFP
fusion partners (i.e., increased proximity of the fluorophores), and is
associated with increased Ca2 release through the RyR channel
(see Figures 5 and 6).
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vides a powerful platform for a more detailed analysis of the
specific role of RyR2 regulation by intramolecular interac-
tion in disease phenotypes.
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